Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01553539 · OUTCOME

Overall Survival

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery · Source last updated 2018-07-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
Approximately 5 years

Groups in this outcome

Treatment (Antiangiogenesis Therapy)

Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Antiangiogenesis Therapy)20

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)10.2Not reported5.318.3Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        5.3
        upper Limit
        18.3
        value
        10.2
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.
    id
    OG000
    title
    Treatment (Antiangiogenesis Therapy)
param Type
MEDIAN
reporting Status
POSTED
time Frame
Approximately 5 years
title
Overall Survival
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice